David C. Stoppel

583 total citations
6 papers, 435 citations indexed

About

David C. Stoppel is a scholar working on Cognitive Neuroscience, Genetics and Molecular Biology. According to data from OpenAlex, David C. Stoppel has authored 6 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cognitive Neuroscience, 5 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in David C. Stoppel's work include Autism Spectrum Disorder Research (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Genetic Syndromes and Imprinting (2 papers). David C. Stoppel is often cited by papers focused on Autism Spectrum Disorder Research (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Genetic Syndromes and Imprinting (2 papers). David C. Stoppel collaborates with scholars based in United States. David C. Stoppel's co-authors include Matthew P. Anderson, Zhe Jin, Yudong Zhou, Stephen Smith, Guangping Zhang, Ekim Özkaynak, Ekkehard M. Kasper, Monica J. S. Nadler, Mark F. Bear and Yi Nong and has published in prestigious journals such as Nature, The Journal of Cell Biology and Science Translational Medicine.

In The Last Decade

David C. Stoppel

6 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David C. Stoppel United States	6	298	265	187	79	34	6	435
Volker Endris Germany	3	320 1.1×	243 0.9×	229 1.2×	87 1.1×	49 1.4×	6	467
Samuel W. Hulbert United States	8	196 0.7×	208 0.8×	178 1.0×	74 0.9×	18 0.5×	9	376
Hannah M. Grayton United Kingdom	7	276 0.9×	238 0.9×	158 0.8×	91 1.2×	29 0.9×	7	470
Audrey Guilmatre United States	8	358 1.2×	401 1.5×	108 0.6×	134 1.7×	26 0.8×	9	664
Véronique Saywell France	7	253 0.8×	214 0.8×	166 0.9×	97 1.2×	36 1.1×	7	452
Lionel Host France	9	176 0.6×	297 1.1×	84 0.4×	98 1.2×	25 0.7×	10	437
Danilo Bernardo United States	4	220 0.7×	243 0.9×	121 0.6×	146 1.8×	21 0.6×	7	404
Hélène Cheval France	7	492 1.7×	428 1.6×	284 1.5×	79 1.0×	27 0.8×	9	673
Christine Ochoa Escamilla United States	6	176 0.6×	168 0.6×	131 0.7×	49 0.6×	30 0.9×	6	305
Adele Mossa Italy	6	136 0.5×	132 0.5×	117 0.6×	70 0.9×	24 0.7×	8	260

Countries citing papers authored by David C. Stoppel

Since Specialization

Citations

This map shows the geographic impact of David C. Stoppel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Stoppel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Stoppel more than expected).

Fields of papers citing papers by David C. Stoppel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Stoppel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Stoppel. The network helps show where David C. Stoppel may publish in the future.

Co-authorship network of co-authors of David C. Stoppel

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Stoppel. A scholar is included among the top collaborators of David C. Stoppel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Stoppel. David C. Stoppel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Stoppel, David C., et al.. (2021). mGluR5 Negative Modulators for Fragile X: Treatment Resistance and Persistence. Frontiers in Psychiatry. 12. 718953–718953. 23 indexed citations

2.

Lewis, Michael C., Arnold J. Heynen, David C. Stoppel, et al.. (2020). Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome. Science Translational Medicine. 12(544). 43 indexed citations

3.

Stoppel, David C. & Matthew P. Anderson. (2017). Hypersociability in the Angelman syndrome mouse model. Experimental Neurology. 293. 137–143. 20 indexed citations

4.

Krishnan, Vaishnav, David C. Stoppel, Yi Nong, et al.. (2017). Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1. Nature. 543(7646). 507–512. 112 indexed citations

5.

Tata, Aleksandra, David C. Stoppel, Shangyu Hong, et al.. (2014). An image-based RNAi screen identifies SH3BP1 as a key effector of Semaphorin 3E–PlexinD1 signaling. The Journal of Cell Biology. 205(4). 573–590. 23 indexed citations

6.

Smith, Stephen, Yudong Zhou, Guangping Zhang, et al.. (2011). Increased Gene Dosage of Ube3a Results in Autism Traits and Decreased Glutamate Synaptic Transmission in Mice. Science Translational Medicine. 3(103). 103ra97–103ra97. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact